Sign in

    Sleep Number Corp (SNBR)

    You might also like

    Sleep Number Corporation is a wellness technology company that specializes in the design, manufacturing, marketing, and distribution of innovative sleep solutions. The company is dedicated to improving the health and well-being of society through higher-quality sleep, offering products that integrate physical and digital innovations. Sleep Number sells smart beds, adjustable bases, and bedding, primarily to individual consumers in the United States through various retail channels.

    1. 360 Smart Beds - Offers personalized comfort with firmness adjustability and embedded digital sensors that learn individual sleep needs. Features "sense and do" technology for automatic adjustments and active temperature balancing for an ideal sleep climate.
    2. Smart Adjustable Bases - Complements smart beds by providing adjustable support and enhancing the overall sleep experience.
    3. Bedding - Includes a range of products designed to work with smart beds to enhance sleep quality.
    NamePositionStart DateShort Bio
    Shelly R. IbachChair, President, and CEOApril 2007Joined as SVP of U.S. Sales; promoted to President and CEO in June 2012 and Chair in May 2022. Announced retirement effective no later than the 2025 Annual Meeting.
    Francis K. LeeEVP and CFOAugust 14, 2023Joined with extensive finance experience; previously CFO at Wyze Labs and held leadership roles at Nike and Gap Inc..
    Christopher D. KrusmarkEVP and Chief Human Resources Officer2005Held various leadership roles; promoted to current position in July 2020. Served as Interim CFO from January 2023 to August 2023.
    J. Hunter SakladEVP and Chief Supply Chain OfficerOctober 2004Leads sourcing, procurement, and manufacturing; promoted to current role in January 2021. Previously served as SVP and CIO.
    Melissa BarraEVP and Chief Sales and Services OfficerFebruary 2013Held various leadership roles; promoted to current position in December 2020. Previously worked at Best Buy, Citibank, and GE Capital.
    Andrea L. BloomquistEVP and Chief Innovation OfficerMay 2008Leads sleep innovation strategy; promoted to current role in December 2020. Previously held leadership roles at Macy’s and Target.
    Kevin K. BrownEVP and Chief Marketing Officer2014Leads brand marketing and communications; promoted to current role in December 2020. Previously held leadership roles at Meijer, Sears, and Accenture.
    Samuel R. HellfeldEVP, Chief Legal and Risk Officer, and SecretaryMarch 2013Leads legal, audit, and risk functions; promoted to current role in March 2022. Previously a Partner at Fox Rothschild LLP.
    Michael J. HarrisonUpcoming Independent Chair of the BoardAfter 2025 Annual MeetingIndependent Board member since 2011; currently Lead Director since May 2022. Set to become Independent Chair after the 2025 Annual Meeting.
    1. Given that you did not experience the expected demand improvement in Q3 and are not planning for improvement in Q4, what specific actions are you taking to stimulate consumer demand amid ongoing macroeconomic challenges?
    2. With operating expenses reduced by $17 million in Q3 and $60 million year-to-date, are these cost reductions sustainable without impacting your ability to invest in growth and innovation initiatives?
    3. How does the upcoming retirement of CEO Shelly Ibach impact the company's strategic direction, and what plans are in place to ensure a smooth leadership transition during this challenging period?
    4. Given that financing approval rates and usage have slightly declined, how significant is this trend, and what measures are you taking to mitigate the impact of tighter consumer financing conditions on sales?
    5. With consumer spending being more concentrated around promotional events and cautious shopping behavior outside of holidays, how are you adjusting your marketing and promotional strategies to drive sales during non-peak periods?
    Program DetailsProgram 1
    Approval DateApril 4, 2021
    End Date/DurationNo expiration date
    Total Additional Amount$600 million
    Remaining Authorization$348 million (as of 2024-09-28)
    DetailsBoard-approved program with no set expiration